These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15035151)

  • 41. New biomarkers of bone resorption.
    Eyre D
    J Clin Endocrinol Metab; 1992 Mar; 74(3):470A-470C. PubMed ID: 1740477
    [No Abstract]   [Full Text] [Related]  

  • 42. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
    Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
    Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of clodronate in patients with multiple myeloma. Evaluation of specific markers of bone resorption].
    Slabý J; Spicka I; Hulejová H; Spacek P; Cieslar P; Klener P
    Cas Lek Cesk; 1997 Jan; 136(2):57-60. PubMed ID: 9147856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
    Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
    J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Biochemical basis of bone resorption markers].
    Ichimura S; Iwamoto J
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():228-35. PubMed ID: 11979912
    [No Abstract]   [Full Text] [Related]  

  • 47. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
    Yamauchi M
    Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
    J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Free deoxypyridinoline in urine and serum--results in children and adolescents.
    Rauch F; Middelmann B; Rosmalen F; Seibel MJ; Schönau E
    Exp Clin Endocrinol Diabetes; 1996; 104(5):396-9. PubMed ID: 8957276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term urine deoxypyridinoline biological variability in the first 5 years after menopause.
    Di Stefano M; Formoso F; Tamone C; Aimo G; Mengozzi G; Bergui S; Isaia GC
    Clin Chem; 2005 Nov; 51(11):2189-92. PubMed ID: 16244301
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of antiresorptive therapy on day-to-day variation of urinary free deoxypyridinoline excretion.
    Fradinger EE; Rodriguez G; Bogado C; Zanchetta JR
    Clin Chem; 1998 Oct; 44(10):2224-5. PubMed ID: 9761272
    [No Abstract]   [Full Text] [Related]  

  • 52. Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison.
    Bettica P; Baylink DJ; Moro L
    Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):459-65. PubMed ID: 8399787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Gamma-GTP].
    Ikeda K
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():110-4. PubMed ID: 18161092
    [No Abstract]   [Full Text] [Related]  

  • 54. Big future in store for biochemical bone markers.
    Titus K
    CAP Today; 1996 Feb; 10(2):5, 8. PubMed ID: 10160262
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pyridinoline and deoxypyridinoline].
    Okazaki R
    Nihon Rinsho; 1999 Sep; 57 Suppl():201-5. PubMed ID: 10543087
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary immunoreactive deoxypyridinoline in children and adolescents: variations with age, sex and growth velocity.
    Rauch F; Rauch R; Woitge HW; Seibel MJ; Schönau E
    Scand J Clin Lab Invest; 1996 Dec; 56(8):715-9. PubMed ID: 9034352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a HPLC method for measurement of collagen crosslinks in urine-potential biomarkers for osteoporosis.
    Casserly UM; McGuinness BJ; Power MJ; Fottrell PF
    Biochem Soc Trans; 1995 May; 23(2):385S. PubMed ID: 7672418
    [No Abstract]   [Full Text] [Related]  

  • 58. Measurements of deoxypyridinoline and hydroxyproline in 24-h, first morning, and second morning urine samples.
    Leino A; Impivaara O; Kaitsaari M
    Clin Chem; 1996 Dec; 42(12):2037-9. PubMed ID: 8969647
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of an internal standard to measure pyridinoline and deoxypyridinoline in urine.
    Calabresi E; Lasagni L; Franceschelli F; Bartolini L; Serio M; Brandi ML
    Clin Chem; 1994 Feb; 40(2):336-7. PubMed ID: 8313615
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison study of urinary pyridinoline and deoxypyridinoline measurements in 13 US laboratories.
    Vesper HW; Smith SJ; Audain C; Myers GL
    Clin Chem; 2001 Nov; 47(11):2029-31. PubMed ID: 11673372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.